Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

US Patent 10906916 · Granted Feb 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods using HDAC11 inhibitors2025
Compounds and compositions for the inhibition of NAMPT2025
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2025
Carboxamides as ubiquitin-specific protease inhibitors2024
Activating pyruvate kinase R2024
Activating pyruvate kinase R2024
IRAK degraders and uses thereof2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators2024
Treating sickle cell disease with a pyruvate kinase R activating compound2024